Pentixapharm Holding AG (ETR:PTP) | WebDisclosure

Basculer en Français

11294	Companies
250971	Keywords
179882	Articles
136840	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

PRESS RELEASE

published on 10/01/2024 at 18:48, 2 years 1 month ago

EQS-Adhoc: Pentixapharm Holding AG: Placement Price Set at EUR 5.10 per Share, All 3.9 Million Offer Shares Placed
Pentixapharm Holding AG sets IPO placement price at EUR 5.10 per share, placing all 3.9 million offer shares. Gross proceeds reach EUR 19.9 million. Post-money market capitalization at EUR 126.5 million

IPO Market Capitalization Pentixapharm Holding AG Placement Price Offer Shares
PRESS RELEASE

published on 09/24/2024 at 11:51, 2 years 1 month ago

Original-Research: Pentixapharm Holding AG (von BankM AG): n.a.
Pentixapharm Holding AG von BankM AG eingestuft. Präziser Theranostic-Ansatz mit validiertem Target. Potenzial in Präzisionsonkologie. Risikoadjustierte Bewertung des Eigenkapitals. Vollständige Analyse unter: http://www.more-ir.de/d/30855.pdf

BankM AG Pentixapharm Holding AG Theranostic-Ansatz Präzisionsonkologie Bewertung Eigenkapital
BRIEF

published on 09/23/2024 at 12:20, 2 years 1 month ago

Pentixapharm Holding AG Sets Price Range for Planned IPO

Frankfurt Stock Exchange Clinical Trials IPO Radiopharmaceuticals Pentixapharm
BRIEF

published on 09/23/2024 at 12:20, 2 years 1 month ago

Pentixapharm Holding AG fixe la fourchette de prix de son introduction en bourse

Bourse De Francfort Essais Cliniques Introduction En Bourse Produits Radiopharmaceutiques Pentixapharm
PRESS RELEASE

published on 09/23/2024 at 12:15, 2 years 1 month ago

Pentixapharm Holding AG Sets Price Range for Planned IPO
Pentixapharm Holding AG sets price range of EUR 4.70 to EUR 6.00 per share for planned IPO to fund product pipeline development in radioligand therapies

IPO Financial Resources Price Range Pentixapharm Holding AG Radioligand Therapies
BRIEF

published on 09/12/2024 at 15:05, 2 years 1 month ago

Pentixapharm Holding AG Plans IPO on Frankfurt Stock Exchange

Frankfurt Stock Exchange Cancer Treatment IPO Radiopharmaceuticals Phase III Trials
BRIEF

published on 09/12/2024 at 15:05, 2 years 1 month ago

Pentixapharm Holding AG envisage une introduction en bourse à Francfort

Bourse De Francfort Introduction En Bourse Traitement Du Cancer Produits Radiopharmaceutiques Essais De Phase III
PRESS RELEASE

published on 09/12/2024 at 15:00, 2 years 1 month ago

Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange
Pentixapharm Holding AG, a subsidiary of Eckert & Ziegler SE, plans IPO on the Prime Standard of the Frankfurt Stock Exchange, focusing on innovative radiopharmaceuticals for theranostics of various indications

Frankfurt Stock Exchange IPO Radiopharmaceuticals Pentixapharm Holding AG Theranostics

Accesswire

Published on 11/06/2026 at 22:15, 1 day 23 hours ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 9 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 9 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 9 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 2 days 12 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/08/2026 at 12:10, 9 hours 51 minutes ago

GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 11 hours 46 minutes ago

2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 1 day 8 hours ago

Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 2 days 1 hour ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 2 days 1 hour ago

L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication

Les Echos

Published on 11/06/2026 at 19:06, 2 days 2 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 2 days 2 hours ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 2 days 2 hours ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 2 days 3 hours ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 18:00, 2 days 4 hours ago

ICADE - CP - Notation crédit S&P

View all LES ECHOS COMFI WIRE